BIOMAT Database Logo BIOMAT Database Logo

Enzymatic amplification of the human immunodeficiency virus in peripheral blood mononuclear cells from pediatric patients. 1989

E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois.

The presence of the human immunodeficiency virus type 1 (HIV) provirus was assessed in peripheral blood mononuclear cells (PBMCs) from 27 offspring of HIV-infected mothers, 12 of these mothers, and 4 HIV-uninfected mother-infant control pairs. Enzymatic amplification of specific conserved regions of the gag and env genes was performed directly in PBMC lysates using the polymerase chain reaction (PCR) technique. The enzymatically amplified gene products were evaluated using the oligomer hybridization detection procedure. PBMCs from infected infants (as determined by Centers for Disease Control clinical criteria) and from HIV-infected mothers manifested a characteristic HIV oligomer hybridization product. Clinically uninfected seropositive infants with declining HIV antibody titers and infants who became seronegative lacked an enzymatically amplified HIV gene product. These preliminary data indicate that PCR is a valuable diagnostic technique to detect or exclude HIV infection in young infants and children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006683 HLA-DQ Antigens A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-DC Antigens,HLA-MB Antigens,HLA-DC,HLA-DQ,HLA-DS,HLA-DS Antigens,HLA-LB,HLA-LB Antigens,HLA-MB,Antigens, HLA-DC,Antigens, HLA-DQ,Antigens, HLA-DS,Antigens, HLA-LB,Antigens, HLA-MB,HLA DC Antigens,HLA DQ Antigens,HLA DS Antigens,HLA LB Antigens,HLA MB Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.
July 1994, Antimicrobial agents and chemotherapy,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.
November 1988, Journal of clinical microbiology,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Enzymatic assay for measurement of intracellular DXG triphosphate concentrations in peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected patients.
January 2003, Antimicrobial agents and chemotherapy,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Quantitation of intracellular triphosphate of emtricitabine in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients.
September 1999, Antimicrobial agents and chemotherapy,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Intracellular efavirenz levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals.
February 2008, Antimicrobial agents and chemotherapy,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Effective use of frozen donor peripheral blood mononuclear cells for human immunodeficiency virus type 1 isolation from vertically infected pediatric patients.
May 1994, Journal of clinical microbiology,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Patterns of interferon-gamma production by peripheral blood mononuclear cells from patients with human immunodeficiency virus infection.
April 1990, Journal of interferon research,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Development of enzymatic assays for quantification of intracellular lamivudine and carbovir triphosphate levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients.
January 2002, Antimicrobial agents and chemotherapy,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues.
October 1988, Blood,
E G Chadwick, and R Yogev, and S Kwok, and J J Sninsky, and D E Kellogg, and S M Wolinsky
CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells.
December 1996, The Journal of general virology,
Copied contents to your clipboard!